SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : A US National Health Care System?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Road Walker who wrote (13362)2/9/2010 11:24:07 AM
From: Lane3  Read Replies (2) of 42652
 
As usual around here a detour from the central point.

I wasn't attempting a detour. Perhaps it would have been better to make my point straight out.

I don't know how you can compete on drugs. Some of them are basically equivalents, others approximations that don't work equally on everyone, others unique. (An example of an equivalent is Lipitor, a statin to which I am allergic although I can tolerate other statins.) I don't see how you could limit your pharmacopoeia that way. Even if you could, you'd need government representatives to establish categories of drugs, evaluate equivalence, and open a bidding process accordingly. When new drugs are introduced into the market, assuming for the sake of argument that that would happen with the same frequency as it now does, you'd have to find a way either to adjust the interplay in real time or wait until the next bidding cycle to make the new drug available. The mind boggles at the thought.

I find it ironic to see competition advocated as a way to acquire drugs for an anti-competitive system. <g>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext